YARCHOAN Lab

Our laboratory is focused on translational immunotherapy research for primary liver cancers, including hepatocellular carcinoma (HCC), cholangiocarcinoma, and fibrolamellar hepatocellular carcinoma (FLC).

Progress in liver cancer has lagged some other tumor types, and the prognosis of liver cancers remains poor. Until we eliminate suffering and death due to liver cancer, we are 100% dedicated to studying the diverse aspects of liver cancers in the lab and in the clinic.